Details
| Stereochemistry | UNKNOWN |
| Molecular Formula | C21H27NO3 |
| Molecular Weight | 341.444 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
OC1CN(C1)C(=O)CC2(C3CC4CC2CC(C3)C4O)C5=CC=CC=C5
InChI
InChIKey=OAAZMUGLOXGVNH-UHFFFAOYSA-N
InChI=1S/C21H27NO3/c23-18-11-22(12-18)19(24)10-21(15-4-2-1-3-5-15)16-6-13-7-17(21)9-14(8-16)20(13)25/h1-5,13-14,16-18,20,23,25H,6-12H2
Approval Year
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Preferred Name | English | ||
|
Systematic Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
HLF8J24L87
Created by
admin on Tue Apr 01 16:52:37 GMT 2025 , Edited by admin on Tue Apr 01 16:52:37 GMT 2025
|
PRIMARY | |||
|
BMS-816336
Created by
admin on Tue Apr 01 16:52:37 GMT 2025 , Edited by admin on Tue Apr 01 16:52:37 GMT 2025
|
PRIMARY | Official Title: Randomized, Placebo-Controlled, Single Ascending Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of BMS-816336 in Healthy Male Subjects;Purpose: The purpose of this study is to evaluate the safety, tolerability and pharmacokinetics following single oral doses of BMS-816336 in healthy male subjects. | ||
|
1009583-20-3
Created by
admin on Tue Apr 01 16:52:37 GMT 2025 , Edited by admin on Tue Apr 01 16:52:37 GMT 2025
|
PRIMARY | |||
|
59336911
Created by
admin on Tue Apr 01 16:52:37 GMT 2025 , Edited by admin on Tue Apr 01 16:52:37 GMT 2025
|
PRIMARY |
ACTIVE MOIETY
